DNA vaccines for the treatment of prostate cancer

Expert Review of Vaccines
Sheeba Alam, Douglas G McNeel

Abstract

Prostate cancer is a significant public health problem, and the most commonly diagnosed cancer in the USA. The long natural history of prostate cancer, the presence of a serum biomarker that can be used to detect very early recurrences, and the previous identification of multiple potential tissue-specific target antigens are all features that make this disease suitable for the development of anti-tumor vaccines. To date, many anti-tumor vaccines have entered clinical testing for patients with prostate cancer, and some have demonstrated clinical benefit. DNA vaccines represent one vaccine approach that has been evaluated in multiple preclinical models and clinical trials. The safety, specificity for the target antigen, ease of manufacturing and ease of incorporating other immune-modulating approaches make DNA vaccines particularly relevant for future development. This article focuses on DNA vaccines specifically in the context of prostate cancer treatment, focusing on antigens targeted in preclinical models, recent clinical trials and efforts to improve the potency of these vaccines.

References

Feb 1, 1992·Human Gene Therapy·S JiaoJ A Wolff
Mar 23, 1990·Science·J A WolffP L Felgner
Apr 25, 1991·The New England Journal of Medicine·W J CatalonaG L Andriole
Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·R S WilliamsJ C Sanford
Dec 1, 1994·Vaccine·I Danko, J A Wolff
Jul 1, 1994·The Journal of Experimental Medicine·A N Houghton
Jun 15, 1996·The Journal of Clinical Investigation·U R HenggeJ C Vogel
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·K SuzueR A Young
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·R E ReiterO N Witte
Jun 1, 1996·Nature Biotechnology·V BudkerJ A Wolff
Jul 3, 1998·International Journal of Cancer. Journal International Du Cancer·A TreisterI P Witz
Sep 17, 1998·The Journal of Clinical Investigation·L W WeberA N Houghton
May 11, 1999·JAMA : the Journal of the American Medical Association·C R PoundP C Walsh
Jan 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G HartmannA M Krieg
Jan 13, 2001·Current Opinion in Immunology·S Gallucci, P Matzinger
Apr 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M P VeldersW M Kast
Nov 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A BiragynL W Kwak
Dec 12, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L FongE G Engleman
Feb 28, 2002·Trends in Immunology·Robert P A WallinHans-Gustaf Ljunggren
Oct 23, 2003·Seminars in Oncology·Jedd D WolchokHoward I Scher
Dec 10, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Julian Gomez-CambroneroMichael A Baumann
Jul 13, 2004·The Journal of Investigative Dermatology·Achim SchneebergerStephan N Wagner

❮ Previous
Next ❯

Citations

Mar 14, 2012·Current Opinion in Oncology·Emmanuel S Antonarakis, Charles G Drake
Feb 14, 2012·Current Opinion in Urology·Charles G Drake, Emmanuel S Antonarakis
Sep 29, 2011·The Cancer Journal·Charles G Drake
Aug 4, 2011·Advances in Urology·Naveed H AkhtarScott T Tagawa
Oct 11, 2012·Genetic Vaccines and Therapy·Sarfraz AhmadMark Tangney
Jan 31, 2014·Cancer Metastasis Reviews·Michael T Schweizer, Charles G Drake
Oct 18, 2011·European Urology·Steven JoniauSusanne Osanto
Jul 1, 2015·Human Vaccines & Immunotherapeutics·A J Graves, D A Hokey
Oct 10, 2013·International Journal of Cancer. Journal International Du Cancer·Jinming LiLunan Wang
Jan 1, 2013·Vaccines·Kouji KobiyamaKen J Ishii
Jan 1, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Charles H JonesBlaine A Pfeifer
Oct 2, 2019·Frontiers in Oncology·Adeline N BoettcherJennifer D Wu
Nov 5, 2014·Cancer Immunology Research·Jonathan W Simons

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Douglas G McNeelGeorge Wilding
Current Opinion in Immunology
Freda K StevensonJason Rice
Pathologie-biologie
M Z LadjemiIsabelle Navarro-Teulon
Immunologic Research
Ken LinT-C Wu
Journal of Biomedicine & Biotechnology
Daniela FiorettiMonica Rinaldi
© 2021 Meta ULC. All rights reserved